U.S. Export Controls and China
Congressional research reportMar 24, 2022
Ask Donna
What actually matters in this document.
Text
Updated March 24, 2022
U.S. Export Controls and China
Since 2018, Congress and the executive branch have
revised—through legislation, regulation, and licensing
practices—the U.S. export control system that regulates
dual-use exports (goods and technology that may have both
civilian and military uses). Much of the legislative reform
has focused on controlling emerging and foundational
technologies, strengthening other technology controls and
licensing practices, engaging multilaterally to ensure U.S.
controls are effective, and considering the impact of
controls on the U.S. economy, including the foreign
availability of U.S. products subject to control. Many of
these changes were efforts to address concerns about the
People’s Republic of China’s (PRC or China) pursuit of
civilian and military leadership in advanced technologies
through U.S. commercial ties. Congress plays a key role in
overseeing the reforms it enacted and shaping the U.S.
export control regime to address U.S. national security and
foreign policy concerns, including those posed by China.
China’s Industrial Policies
China’s state-led industrial policies, such as Made in China
2025 (MIC 2025), seek to create competitive advantages for
China in strategic industries, in part by obtaining
technology from U.S. and foreign firms. MIC 2025 aims to
establish China’s leadership in emerging technologies
critical to future commercial, government, and military
capabilities. Priority areas include advanced manufacturing,
aerospace, artificial intelligence, information technology,
new materials, robotics, and semiconductors. China’s
military-civil fusion (MCF) program also seeks to leverage
MIC 2025 technological advancements for military
development. Some experts say that China’s approach blurs
commercial and military distinctions and may challenge the
U.S. export control regime’s ability to distinguish between
military and civilian end use and end users. China’s policies
in strategic sectors often require a PRC partner, frequently
state-tied, to own or otherwise control U.S. technology that
is transferred to China, potentially increasing risks that U.S.
technology could support China’s military.
U.S. Dual-Use Export Controls
The Export Control Reform Act of 2018 (ECRA) (P.L. 115232) reestablished nonemergency authority for the
President to control dual-use exports for national security
and foreign policy reasons and to coordinate with
multilateral export control regimes, and provided policy
requirements for setting controls. The Bureau of Industry
and Security (BIS) of the Department of Commerce
administers dual-use export controls and chairs an
interagency process that includes the Departments of
Defense (DOD), State, and Energy. BIS administers these
controls through the Export Administration Regulations
(EAR, 15 C.F.R. 730 et seq.), which includes the
Commerce Control List (CCL) of dual-use technologies
subject to controls. The EAR sets licensing policy for
specific destinations, end use, and end user controls. On the
CCL, national security (NS) controlled items are on the
Wassenaar Arrangement’s multilateral control list. The
EAR presumes denial for license applications of NS items
that would make a direct and significant contribution to
China’s military. Separate statutes and regulations control
nuclear materials and technology and defense articles and
services. U.S. law has prohibited arms sales to China since
1989. Congress has also mandated a policy of denial for
exports of satellite and space equipment to China.
Figure 1. 2020 U.S. Exports to China and BIS Actions
Source: CRS with reporting data from BIS.
Note: EAR99 items are subject to the EAR, but are not controlled.
Percentages are based on the value of U.S. exports.
U.S. Licensing Approach
The U.S. government only controls or restricts a small
percentage of U.S. technology exports to China in practice.
BIS has removed from the CCL or waived licensing
requirements for much of U.S. technology trade to China
since the 1990s as certain technologies have become more
widely available globally and in response to U.S. business
interests in the China market. Before new rules in May
2020, BIS waived license requirements for NS items
destined for civilian end use in China in sectors such as
aerospace, computing, and semiconductors. An estimated
18.1% of $124.6 billion in U.S. exports to China in 2020
($22.6 billion) involved dual-use technologies on the CCL
and subject to controls. BIS required licenses for 2.1%, or
$478 million of these CCL technology exports. Most CCL
technology exports—97.9% or $22.1 billion—went to
China without a license. (Figure 1).
Separately, BIS reported that it reviewed $112 billion in
licenses for U.S. software and technology exports to China
in 2020 and denied 2.2% ($471 million). The $112 billion
in licenses in 2020 increased from $6.9 billion in 2019; the
increase might reflect licenses, including for EAR 99 items,
required for PRC firms added to the EL since 2019. EAR
99 includes nonsensitive products and potentially sensitive
technologies in light of China’s dual-use programs. ECRA
called for a review of the CCL and EAR99 to determine
whether some EAR99 technologies should be added to the
CCL. In 2020, BIS denied three of 482 licenses to release
U.S.-controlled technology and knowhow to PRC nationals.
https://crsreports.congress.gov
U.S. Export Controls and China
BIS Entity List
Since 2018, the U.S. government has increased use of the
BIS Entity List (EL) to restrict some dual-use trade with
China by placing certain PRC firms of concern on the list.
The EL identifies persons involved, or with the potential to
be involved, in activities contrary to U.S. national security
or foreign policy interests. BIS typically requires a license
for any U.S. export of EAR items to those listed. EL listings
often presume an export denial, but licensing guidance—
such as narrow or low technology thresholds, partial listing
of firms, and case-by-case approval—appears to facilitate
the export of some U.S. technology and CCL items to PRC
firms on the EL. A lack of restrictions on 4G, 6G, cloud,
and, until recently, undersea cable technologies has allowed
Huawei to purchase U.S. technology. In 2020, Huawei sold
its Honor 5G mobile business to the PRC government. BIS
has not added Honor to the EL to extend Huawei
restrictions to the firm. EL restrictions for China’s foundry,
Semiconductor Manufacturing International Corporation
(SMIC), apply to technology below 10 nanometers (nm),
allowing trade at and above 14 nm to continue. In October
2021, the House Foreign Affairs Committee released BIS
licensing data for Huawei and SMIC from November 2020
to April 2021. Much of it involved semiconductor
technology: BIS approved 113 licenses for Huawei ($61.4
billion); and returned 48 ($29.8 billion) without action. BIS
approved 188 licenses for SMIC ($41.9 billion), and
returned 17 ($1.2 billion) without action.
Clarifying that existing U.S. controls apply to re-
In August 2020, BIS amended the foreign-direct product
rule to restrict Huawei’s ability to acquire chips from any
source using U.S.-controlled equipment or software, such as
TSMC in Taiwan; other PRC firms are not restricted. In
April 2021, BIS added PRC firm Pythium to the EL for the
firm’s role in China’s hypersonic weapons program—BIS
does not appear to restrict Pythium’s and other PRC firms’
use of U.S. open source technology platforms and U.S.
software tools to design and test advanced chips for China’s
strategic advanced computing programs. In December
2021, BIS added China’s Academy of Military Medical
Sciences and eleven of its institutes to the EL; these
controls may not pertain to U.S. research ties with China.
Issues for Congress
Some Members have expressed concerns about a slow pace
of implementing some of the reforms required by statute.
For example, while BIS has initiated a rulemaking process
for emerging technologies and proposed an approach for
foundational technologies, it has established few new
controls. This, some argue, could impede congressional
reforms that expanded the authority of the Committee on
Foreign Investment in the United States (CFIUS) to review
PRC and other foreign investments in critical and emerging
technologies below thresholds of foreign control. Issues for
possible oversight or legislative action include:
Military-Tied Firms
In late 2020, BIS extended licensing requirements for PRC
firms identified as military-end users; it presumed denial for
certain, but not all, CCL exports to these firms. Many PRC
military firms do not appear to be on the BIS military-end
users list or the EL. The BIS lists include a subset of the
PRC military firms that Congress requires DOD to identify
in accordance with Section 1260H of the National Defense
Authorization Act for Fiscal Year 2021 (P.L. 116-283). In
some cases, BIS lists only parts of these firms.
ECRA Reforms
ECRA has provisions—which impact U.S. dual-use exports
to China—to reform or augment export control decisionmaking, licensing, and technology controls, including:
Determining foreign availability by considering
comparable quality in ascertaining whether a global
alternative is comparable to a U.S. technology. Foreign
availability determinations can affect decisions on
whether to apply specific or general controls.
exports, regardless of the structure of the underlying
transaction, including identifying and considering any
foreign party to a license with a significant ownership
interest. This requires more detail on ultimate end users
and scrutiny of joint ventures. Additionally, after the
U.S. government decision in June 2020 to no longer
treat Hong Kong separately from China, BIS imposed
new licensing conditions for U.S. exports to Hong Kong
and re-exports from Hong Kong to mainland China.
Requiring the President to create an interagency process
to create controls on “emerging and foundational
technologies” of concern—including through a review
of the CCL—and regulate their release to foreign
persons by, at a minimum, requiring an export license.
Reviewing the interagency dispute resolution process
and requiring BIS to work with DOD on commodity
classifications to determine when a license is required.
Adding a role for the Director of National Intelligence
and considering the U.S. industrial base in setting
controls and in licensing decisions.
Defining dual-use to include law-enforcement
applications. Relatedly, crime control equipment exports
to China require a license. Concerns about China’s
human rights abuses and surveillance activities have led
to tighter scrutiny of these exports to China.
The status of ECRA implementation and whether the pace and
scope of actions are sufficient without greater oversight or
changes to the export control regime.
The impact of the pace and scope of ECRA’s implementation
on other congressional reforms like CFIUS.
The global context of export controls and practices to ascertain
whether to pursue more multilateral controls and reforms.
The status of controlling emerging and existing technologies,
and reforming the process for classification determinations and
licensing decisions, including for escalated cases.
The operating committee’s current voting structure and BIS’s
role as chair in determining licensing decision outcomes.
The level of congressional scrutiny of licensing decisions,
justifications, waivers, and exceptions, and whether to pursue
more frequent and regularized reporting to Congress to
strengthen its oversight of export controls in practice.
Karen M. Sutter, Specialist in Asian Trade and Finance
Christopher A. Casey, Analyst in International Trade and
Finance
https://crsreports.congress.gov
IF11627
U.S. Export Controls and China
Disclaimer
This document was prepared by the Congressional Research Service (CRS). CRS serves as nonpartisan shared staff to
congressional committees and Members of Congress. It operates solely at the behest of and under the direction of Congress.
Information in a CRS Report should not be relied upon for purposes other than public understanding of information that has
been provided by CRS to Members of Congress in connection with CRS’s institutional role. CRS Reports, as a work of the
United States Government, are not subject to copyright protection in the United States. Any CRS Report may be
reproduced and distributed in its entirety without permission from CRS. However, as a CRS Report may include
copyrighted images or material from a third party, you may need to obtain the permission of the copyright holder if you
wish to copy or otherwise use copyrighted material.
https://crsreports.congress.gov | IF11627 · VERSION 5 · UPDATED
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.